Sustainable Insect-based Protein Supplement in the Elderly: a Pilot Study
SIPSE
2 other identifiers
interventional
30
1 country
1
Brief Summary
This pilot randomized, double-blind, controlled trial evaluated the effects of a Tenebrio molitor-enriched protein biscuit combined with a structured physical activity program on cardiometabolic health in older adults. Participants aged 65 years and older were assigned to receive either insect-based or control biscuits following supervised exercise sessions for 28 days. Primary outcomes focused on changes in lipid profile, while secondary outcomes included anthropometric measures, body composition, blood pressure, physical function, glucose metabolism, hepatic function and inflammatory biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2024
CompletedFirst Submitted
Initial submission to the registry
February 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedMarch 9, 2026
February 1, 2026
8 months
February 11, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lipid profile
Changes in lipid profile (total cholesterol, LDL-C, HDL-C, triglycerides) and lipid particles (small, medium and large lipoproteins) Description: Changes in the lipid profile were assessed by measuring fasting plasma concentrations of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides at baseline and after the intervention. In addition, detailed lipoprotein particle profiling was performed to quantify the concentration and size distribution of lipoproteins, including small, medium, and large subclasses of LDL, HDL, and very-low-density lipoproteins (VLDL). These measures allowed evaluation of both conventional lipid parameters and qualitative changes in lipoprotein particle composition associated with the intervention.
One month (baseline and after the intervention)
Secondary Outcomes (15)
Body Weight (Kg)
Baseline to 28 days
Change in blood pressure (mmHg) .
Baseline to 28 days
Change in Handgrip Strength (kg)
Baseline to 28 days
Change in glucose (mg/dL).
Baseline to 28 days
Change in hepatic enzymes (ALT, AST, GGT)
Baseline to 28 days
- +10 more secondary outcomes
Study Arms (2)
INSECT
EXPERIMENTALParticipants consumed three Tenebrio molitor-enriched cookies per day (35 g insect flour/day) immediately after supervised exercise sessions, three times per week for 28 days.
CONTROL
PLACEBO COMPARATORParticipants consumed three wheat flour-based control cookies per day immediately after supervised exercise sessions, three times per week for 28 days.
Interventions
Participants received a protein suplement in the form of cookies based on edible insect flour.
Eligibility Criteria
You may qualify if:
- Age ≥ 60 years
- Body mass index (BMI) between 18.5 and 30.0 kg/m²
- Mini-Mental State Examination (MMSE) score ≥ 16
- Independent in basic activities of daily living
- Mini Nutritional Assessment-Short Form (MNA-SF) score ≥ 8
- Ability to provide written informed consent
You may not qualify if:
- Food Neophobia Scale score \> 4
- Chronic diseases affecting metabolism or nutritional status
- Dependency or severe functional impairment
- Current or past use of medications or supplements affecting body weight or metabolic function
- Excessive alcohol consumption
- History of eating disorders or psychiatric illness
- Known food allergies (e.g., crustacean allergy) or celiac disease
- Inability or unwillingness to comply with study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UOC
Barcelona, Barcelona, 08018, Spain
Related Publications (4)
Ros-Baro M, Puig MC, Chiva-Blanch G, Diaz-Rizzolo DA, Martinez AA, Rafart MJ, Chiriac I, Rogel MB, Cunill MP, Casas-Agustench P, Bach-Faig A. Enrichment of Pasteurized Dairy Product and Brownie With Edible Insect (Tenebrio molitor) to Analyze Acceptance Using Check-All-That-Apply Methodology. Food Sci Nutr. 2025 Oct 30;13(11):e70925. doi: 10.1002/fsn3.70925. eCollection 2025 Nov.
PMID: 41179365BACKGROUNDRos-Baro M, Casas-Agustench P, Diaz-Rizzolo DA, Batlle-Bayer L, Adria-Acosta F, Aguilar-Martinez A, Medina FX, Pujola M, Bach-Faig A. Edible Insect Consumption for Human and Planetary Health: A Systematic Review. Int J Environ Res Public Health. 2022 Sep 15;19(18):11653. doi: 10.3390/ijerph191811653.
PMID: 36141915BACKGROUNDRos-Baro M, Sanchez-Socarras V, Santos-Pages M, Bach-Faig A, Aguilar-Martinez A. Consumers' Acceptability and Perception of Edible Insects as an Emerging Protein Source. Int J Environ Res Public Health. 2022 Nov 26;19(23):15756. doi: 10.3390/ijerph192315756.
PMID: 36497830BACKGROUNDIshara J, Ekaette I, Matendo R, Vandenberg G, Niassy S, Katcho K, Kinyuru J. Potential health benefits of insect bioactive metabolites and consumer attitudes towards edible insects. NPJ Sci Food. 2025 Sep 26;9(1):195. doi: 10.1038/s41538-025-00549-x.
PMID: 41006283BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Participants and investigators were blinded to group allocation. Intervention cookies were similar in appearance, texture, and palatability.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 11, 2026
First Posted
March 6, 2026
Study Start
May 1, 2024
Primary Completion
December 22, 2024
Study Completion
December 22, 2024
Last Updated
March 9, 2026
Record last verified: 2026-02